# Chugai Pharmaceutical Posts ¥228.07 IFRS EPS for Nine Months

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/42259
Published: 2026-10-28T02:20:16.000Z
Updated: 2026-10-28T02:20:16.000Z
Section: Business

> Revenue was ¥1,068.1 billion for the nine months ended Sept. 30, 2026. The results were dated Oct. 27.

Chugai Pharmaceutical Co., Ltd. recorded IFRS basic and diluted earnings per share of ¥228.07 for the nine months ended Sept. 30, 2026.

Revenue for the period was ¥1,068.1 billion. The financial statements were dated Oct. 27, 2026.